Dong-E-E-Jiao Co Ltd represents values of tradition, innovation, and quality. With a rich history dating back to 1820, the company has established itself as a leading producer of traditional Chinese medicine, particularly specializing in donkey-hide gelatin products. They prioritize the modernization of traditional Chinese medicine while adhering to the core values of preserving the wisdom of ancestors. Dong-E-E-Jiao Co Ltd focuses on providing high-quality products through stringent quality control and continuous research and development. Their corporate philosophy centers around promoting health and well-being by combining modern scientific techniques with traditional medicinal practices. Overall, Dong-E-E-Jiao Co Ltd is committed to upholding their heritage while actively contributing to the advancement of the healthcare industry.

Dong-E-E-Jiao Co Ltd is primarily present in China and operates in various regions across the country.

Dong-E-E-Jiao Co Ltd, a leading company in the health and pharmaceutical industry, has achieved several significant milestones throughout its history. The company has successfully expanded its product portfolio, introducing innovative healthcare solutions to the market. Dong-E-E-Jiao Co Ltd has also established strong partnerships and collaborations with renowned organizations, enabling it to enhance its research and development capabilities. With a commitment to quality and customer satisfaction, Dong-E-E-Jiao Co Ltd has gained a solid reputation in the industry, earning numerous awards and recognitions. Through continuous growth and strategic initiatives, the company has successfully positioned itself as a key player in the health and pharmaceutical sector.

Dong-E-E-Jiao Co Ltd, a renowned company in the stock market, has a rich history and background. Established in [year], Dong-E-E-Jiao Co Ltd has grown to become a leading player in the [industry] sector. The company specializes in [specific products/services]. With a strong focus on innovation and quality, Dong-E-E-Jiao Co Ltd has successfully gained a reputation for excellence in the market. Its commitment to customer satisfaction and continuous growth has propelled it to great heights. Over the years, Dong-E-E-Jiao Co Ltd has demonstrated its ability to adapt to changing market trends and consistently deliver value to its shareholders.

The main competitors of Dong-E-E-Jiao Co Ltd in the market include other Chinese pharmaceutical companies such as Yunnan Baiyao Group Co Ltd and Shijiazhuang Yiling Pharmaceutical Co Ltd. These companies also specialize in traditional Chinese medicines and health products, posing a competitive challenge to Dong-E-E-Jiao Co Ltd.

Dong-E-E-Jiao Co Ltd is primarily active in the healthcare and pharmaceutical industries.

The business model of Dong-E-E-Jiao Co Ltd focuses on manufacturing and selling traditional Chinese medicine products, with a specialization in donkey-hide gelatin-based products. As a renowned company in the healthcare industry, Dong-E-E-Jiao Co Ltd aims to provide high-quality and natural health solutions to its customers. With a strong emphasis on innovation and research, the company strives to maintain its position as a leading provider of traditional Chinese medicine. Dong-E-E-Jiao Co Ltd's commitment to quality and excellence has earned the trust and loyalty of its customers over the years.

De Dong-E-E-Jiao Co K/W is 24,16.

De Dong-E-E-Jiao Co KUV is 6,11.

De AlleAktien Kwaliteitsscore voor Dong-E-E-Jiao Co is 4/10.

De verwachte Dong-E-E-Jiao Co omzet is 5,67 mld. CNY.

De verwachte Dong-E-E-Jiao Co winst is 1,43 mld. CNY.

Dong-E-E-Jiao Co. Ltd is a leading provider of traditional natural remedies in China. The company was founded in 1952 in Shandong, China and has since become one of the most prestigious Chinese companies in the health and wellness market. Their business model is focused on the sale of concentrated black gelatin and other natural effective products. One of the main divisions of the company is the production and sale of EZhu (Knotweed), an important component of traditional Chinese medicine. EZhu is derived from the root of the plant Zedoaria Rhizomata and has antiseptic, anti-inflammatory, and analgesic effects. The company offers various forms of this product such as powder, capsules, and extracts. Another important product of the company is concentrated black gelatin (E-Jiao), which is made from horse blood. This gelatin has a long history in traditional Chinese medicine and is used to nourish blood. Dong-E-E-Jiao produces different forms of this gelatin, such as classic, flavored, and concentrated varieties. The company is also involved in other business areas, such as the production of skincare products and dietary supplements. Their skincare products are made from natural organic ingredients and are marketed under the brand "MIYOSHI MIYAGI". The dietary supplements are tailored to a wide range of consumer needs, such as strength and endurance training or health and wellness. The company distributes its products both domestically and internationally. In China, Dong-E-E-Jiao has an extensive distribution network that works closely with hospitals, clinics, and health centers. Internationally, the company operates outlets in several countries, including Hong Kong, Taiwan, Singapore, the United States, and Canada. An important component of Dong-E-E-Jiao's business model is research and development. The company operates its own research center, focusing on the study of the effectiveness and safety of natural remedies. They also collaborate closely with scientific institutions and external experts to improve their products and develop new innovations. Overall, Dong-E-E-Jiao's business model is focused on the development and marketing of traditional natural remedies. It stands out for its wide range of products tailored to market demands. With its own research center and a strong presence both domestically and internationally, Dong-E-E-Jiao is well positioned to continue growing and better serve its customers worldwide.

Dong-E-E-Jiao Co keert een dividend van 0,66 CNY uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Dong-E-E-Jiao Co of het bedrijf keert geen dividend uit.

De ISIN van Dong-E-E-Jiao Co is CNE0000006Y9.

De ticker van Dong-E-E-Jiao Co is 000423.SZ.

Binnen de laatste 12 maanden betaalde Dong-E-E-Jiao Co een dividend van 1,18 CNY . Dit komt overeen met een dividendrendement van ongeveer 2,19 %. Voor de komende 12 maanden zal Dong-E-E-Jiao Co naar verwachting een dividend van 1,19 CNY betalen.

De dividendrendement van Dong-E-E-Jiao Co is momenteel 2,19 %.

Dong-E-E-Jiao Co betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden september, september, juli, juli.

Dong-E-E-Jiao Co betaalde de afgelopen 23 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 1,19 CNY verwacht. Dit komt overeen met een dividendrendement van 2,33 %.

Dong-E-E-Jiao Co wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van Dong-E-E-Jiao Co van 12-6-2024 ter hoogte van 1,784 CNY te ontvangen, moest je het aandeel voor de ex-datum op 12-6-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 12-6-2024.

In het jaar 2023 heeft Dong-E-E-Jiao Co 0,66 CNY aan dividenden uitgekeerd.

De dividenden van Dong-E-E-Jiao Co worden in CNY uitgekeerd.